Camp4 Therapeutics director Andrew J. Schwab reports disposal of 400,000 common shares valued at $1.62 million
CAMP•Director reports share sale
- Camp4 Therapeutics director Andrew J. Schwab reported a sale of 400,000 common shares on Aug. 27.
- Shares were sold at $4.04 and held indirectly through 5AM Ventures VI.
- The 5AM Ventures VI stake fell to 2,033,270 shares following the transaction.
Related News
NextTrip enters USD 6.5 million at-the-market equity distribution agreement with Titan Partners Securities
NTRP•
Applied Materials director Akash J. Palkhiwala files initial beneficial ownership statement (Form 3)
AMAT•
